SEARCH

SEARCH BY CITATION

Literature Cited

  • 1
    Abo T, Miller CA, Cloud GA, Blach CM: Annual stability in levels of lymphocyte subpopulations identified by monoclonal antibodies in blood of healthy individuals. J Clin Immunol 5: 1320, 1985.
  • 2
    Bishop PC, Boone D, Parker JW: Immunophenotypes by flow cytometry: A longitudinal study in healthy individuals. Diagn Clin Immunol 5: 232240, 1988.
  • 3
    Brown MC, Hoffman RA, Kirchanski SJ: Controls for flow cytometers in hematology and cellular immunology. Ann NY Acad Sci 468: 93103, 1986.
  • 4
    Caldwell CW, Maggi J, Henry LB, Taylor HM: Fluorescence intensity as a quality control parameter in clinical flow cytometry. Am J Clin Pathol 88: 447456, 1987.
  • 5
    Centers for Disease Control Vietnam Experience Study: Health status of Vietnam veterans. II. Physical health. JAMA 259: 27082714, 1988.
  • 6
    Conover WJ: Practical Nonparametric Statistics, 2nd ed. J. Wiley & Sons, New York, 1980, pp 239249.
  • 7
    Conover WJ, Iman RL: Rank transformations as a bridge between parametric and nonparametric statistics. Am Statistician 35: 124129, 1981.
  • 8
    Edwards BS, Shopp GM: Efficient use of monoclonal antibodies for immunofluorescence. Cytometry 10: 9497, 1989.
  • 9
    Fulwyler MJ. Standards for flow cytometry. In: Flow Cytometry and Sorting, Melamed, MR, Mullaney, PF, Mendelsohn (eds). John Wiley & Sons, New York, 1979, pp 351358.
  • 10
    Hainline A: Quality assurance: theoretical and practical aspects. In: Selected Methods in Clinical Chemistry 9. AACC, Washington, DC, 1982, pp 1731.
  • 11
    Hensleigh PA, Waters VB, Herzenberg LA: Human T-lymphocyte differentiation antigens: Effects of blood sample storage on LEU antibody binding. Cytometry 3: 453455, 1983.
  • 12
    Hercend T, Griffin JD, Bensussan A, Schmidt RE, Edson M, Brennan A, Murray C, Daley JF, Schlossman SF, Ritz J: Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest 75: 932943, 1985.
  • 13
    Krensky AM, Lanier LL, Engleman EG: Lymphocyte subsets and surface molecules in man. Clin Immunol Rev 4: 95138, 1985.
  • 14
    Kung PC, Berger CL, Estabrook A, Edelson RL: Monoclonal antibodies for clinical investigation of human T lymphocytes. Int J Dermatol 22: 6774, 1983.
  • 15
    La Via MF, Hurtubise PE, Parker JW, Rubin RH, Burdash NM, Spencer-Green G, Bishop DA, Dziurzynski B: T-lymphocyte subset phenotypes: A multisite evaluation of normal subjects and patients with AIDS. Diagn Immunol 3: 7582, 1985.
  • 16
    Levi FA, Canon C, Blum JP, Mechkouri M, Reinberg A, Mathe G: Circadian and/or circahemidian rhythyms in nine lymphocyte-related variables from peripheral blood of healthy subjects. J Immunol 134: 217222, 1985.
  • 17
    Levi FA, Canon C, Touitou Y, Reinberg A, Mathe G: Seasonal modulation of the circadian time structure of circulating T and natural killer lymphocyte subsets from healthy subjects. J Clin Invest 81: 407413, 1988.
  • 18
    Ludgate ME, Dryden PR, Weetman AP, McGregor AM: T cell subset analysis of cryopreserved human peripheral blood mono-nuclear cells. Immunol Lett 7: 119122, 1983.
  • 19
    Perussia B, Fanning V, Trinchieri G: A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by the antibody OKT8. J Immunol 131: 223231, 1983.
  • 20
    Ritchie AWS, Oswald I, Micklem HS, Boyd JE, Elton RA, Jazwinska E, James K: Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies. Br Med J 286: 17731775, 1983.
  • 21
    Shield CF III, Manlett P, Smith A, Gunter L, Goldstein G: Stability of human leukocyte differentiation antigens when stored at room temperature. J Immunol Methods 62: 347352, 1983.
  • 22
    Thurlow PJ, McKenzie IFC: Monoclonal antibodies in clinical medicine–A review. Aust NZ J Med 13: 91100, 1983.
  • 23
    Weiblen BJ, Debell K, Valeri CR: “Acquired immunodeficiency” of blood stored overnight. N Eng J Med 309: 793, 1983.